Considerations for CPX-351 in Acute Myeloid Leukemia
2 Bekeken
• 07/04/23
0
0
insluiten
administrator
abonnees
Expert panelists Eunice Wang, MD; Harry Erba, MD, PhD; Alexander E. Perl, MD; and Jorge E. Cortes, MD, identify important considerations when treating acute myeloid leukemia with CPX-351, such as its toxicity profile and patient stratification.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties